Scientific Literature Search

Source record

[Pharmacogenetics focused on special phenotypes].

Sano A.

Nihon Shinkei Seishin Yakurigaku Zasshi · 2011-08-01

PMID: 21941850

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic variability in SNCA and Parkinson's disease.

Pihlstrøm L, Toft M.

Neurogenetics · 2011-07-29

DOI: 10.1007/s10048-011-0292-7PMID: 21800132

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.

Seki N, Takahashi Y, Tomiyama H, Rogaeva E, Murayama S, Mizuno Y, Hattori N, Marras C, Lang AE, George-Hyslop PS, Goto J, Tsuji S.

J Hum Genet · 2011-07-28

DOI: 10.1038/jhg.2011.79PMID: 21796139

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.

Goldstein DS, Holmes C, Sewell L, Park MY, Sharabi Y.

Clin Auton Res · 2011-07-28

DOI: 10.1007/s10286-011-0136-4PMID: 21796351

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Biophysics of α-synuclein membrane interactions.

Pfefferkorn CM, Jiang Z, Lee JC.

Biochim Biophys Acta · 2011-07-28

DOI: 10.1016/j.bbamem.2011.07.032PMID: 21819966

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.

Lamberto GR, Torres-Monserrat V, Bertoncini CW, Salvatella X, Zweckstetter M, Griesinger C, Fernández CO.

J Biol Chem · 2011-07-27

DOI: 10.1074/jbc.m111.242958PMID: 21795682

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Enhanced autophagy from chronic toxicity of iron and mutant A53T α-synuclein: implications for neuronal cell death in Parkinson disease.

Chew KC, Ang ET, Tai YK, Tsang F, Lo SQ, Ong E, Ong WY, Shen HM, Lim KL, Dawson VL, Dawson TM, Soong TW.

J Biol Chem · 2011-07-27

DOI: 10.1074/jbc.m111.268409PMID: 21795716

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes.

Crosiers D, Theuns J, Cras P, Van Broeckhoven C.

J Chem Neuroanat · 2011-07-26

DOI: 10.1016/j.jchemneu.2011.07.003PMID: 21810464

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.

Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson's Disease Study Group.

BMC Neurol · 2011-07-25

DOI: 10.1186/1471-2377-11-89PMID: 21781348

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic mutations and functions of PINK1.

Kawajiri S, Saiki S, Sato S, Hattori N.

Trends Pharmacol Sci · 2011-07-23

DOI: 10.1016/j.tips.2011.06.001PMID: 21784538

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue.

Devine MJ, Kaganovich A, Ryten M, Mamais A, Trabzuni D, Manzoni C, McGoldrick P, Chan D, Dillman A, Zerle J, Horan S, Taanman JW, Hardy J, Marti-Masso JF, Healy D, Schapira AH, Wolozin B, Bandopadhyay R, Cookson MR, van der Brug MP, Lewis PA.

PLoS One · 2011-07-22

DOI: 10.1371/journal.pone.0022489PMID: 21799870

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Structural role of compensatory amino acid replacements in the α-synuclein protein.

Losasso V, Pietropaolo A, Zannoni C, Gustincich S, Carloni P.

Biochemistry · 2011-07-22

DOI: 10.1021/bi2007564PMID: 21736378

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

15.097 articles found

[Pharmacogenetics focused on special phenotypes].

Genetic variability in SNCA and Parkinson's disease.

Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.

Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.

Biophysics of α-synuclein membrane interactions.

Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.

Enhanced autophagy from chronic toxicity of iron and mutant A53T α-synuclein: implications for neuronal cell death in Parkinson disease.

Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes.

Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.

Genetic mutations and functions of PINK1.

Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue.

Structural role of compensatory amino acid replacements in the α-synuclein protein.

Filters